Literature DB >> 11772514

A model for the phenotypic presentation of Werner's syndrome.

E L Ostler1, C V Wallis, A N Sheerin, R G A Faragher.   

Abstract

Werner's syndrome (WS) is a valuable model of accelerated ageing and results from mutations in a recQ helicase (wrn). WS fibroblasts show a mutator phenotype, replication fork stalling, increased rates of mean telomeric loss and accelerated cellular senescence. Senescence has been proposed as a candidate mechanism for the ageing of mitotic tissue. However, some mitotic tissues (such as the immune system) seem unaffected in WS. Is this evidence against a role for cell senescence in ageing? Two experiments resolve this paradox (i) the demonstration that the abbreviated replicative lifespan of WS fibroblasts can be corrected by the ectopic expression of telomerase and (ii) the demonstration that T cells derived from WS patients have the mutator phenotype characteristic of the disease but show no reduction in replicative potential. Since T cells can upregulate telomerase naturally these findings are consistent with a model in which the only wrn-mediated deletions that have a significant effect on replicative lifespan are those at or near the telomere. These data are thus supportive of a role for senescence in the ageing of the immune system. Emerging data on divisional counting mechanisms have the potential to produce many other apparent WS "paradoxes". Accordingly, we propose a general model for the phenotypic presentation of WS, which includes a modification of the Olovnikov model of telomere erosion. Somewhat unexpectedly, this predicts that accelerated senescence should not be observed in all telomerase-negative WS cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11772514     DOI: 10.1016/s0531-5565(01)00194-2

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  7 in total

Review 1.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

2.  A functional analysis reveals dependence on the anaphase-promoting complex for prolonged life span in yeast.

Authors:  Troy A A Harkness; Kyla A Shea; Charmaine Legrand; Mayur Brahmania; Gerald F Davies
Journal:  Genetics       Date:  2004-10       Impact factor: 4.562

3.  Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome.

Authors:  Terence Davis; Hannah S E Tivey; Amy J C Brook; Julia W Grimstead; Michal J Rokicki; David Kipling
Journal:  Age (Dordr)       Date:  2012-09-22

4.  Fibroblasts from Werner syndrome patients: cancer cells derived by experimental introduction of oncogenes maintain malignant properties despite entering crisis.

Authors:  Furong Yuan; Meizhen Chen; Peter J Hornsby
Journal:  Oncol Rep       Date:  2010-02       Impact factor: 3.906

Review 5.  Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.

Authors:  Mark C Bagley; Terence Davis; Paola G S Murziani; Caroline S Widdowson; David Kipling
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-04

Review 6.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

7.  p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes.

Authors:  Hannah S E Tivey; Amy J C Brook; Michal J Rokicki; David Kipling; Terence Davis
Journal:  Biogerontology       Date:  2012-10-31       Impact factor: 4.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.